Bioneer Corporation (KOSDAQ:064550)
16,550
+640 (4.02%)
May 30, 2025, 3:30 PM KST
Bioneer Revenue
Bioneer had revenue of 73.91B KRW in the quarter ending March 31, 2025, a decrease of -6.70%. This brings the company's revenue in the last twelve months to 288.67B, up 0.78% year-over-year. In the year 2024, Bioneer had annual revenue of 293.98B with 11.68% growth.
Revenue (ttm)
288.67B
Revenue Growth
+0.78%
P/S Ratio
1.48
Revenue / Employee
765.70M
Employees
562
Market Cap
427.16B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 293.98B | 30.74B | 11.68% |
Dec 31, 2023 | 263.24B | 44.84B | 20.53% |
Dec 31, 2022 | 218.39B | -5.35B | -2.39% |
Dec 31, 2021 | 223.74B | 16.76B | 8.10% |
Dec 31, 2020 | 206.99B | 170.70B | 470.33% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
Peptron | 3.15B |
PharmaResearch | 392.31B |